Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome.

  title={Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome.},
  author={Marlies Wallner and Rodrig Marculescu and Daniel Doberer and Michael Wolzt and Oswald F. Wagner and Libor V{\'i}tek and Andrew C. Bulmer and Karl-Heinz Wagner},
  journal={Clinical science},
  volume={125 5},
Recent epidemiological and clinical data show protection from CVD (cardiovascular disease), all-cause mortality and cancer in subjects with GS (Gilbert's syndrome), which is characterized by a mildly elevated blood bilirubin concentration. The established antioxidant effect of bilirubin, however, contributes only in part to this protection. Therefore we investigated whether mildly elevated circulating UCB (unconjugated bilirubin) is associated with altered lipid metabolism. The study was… 

Tables from this paper

Oxidative Stress and Related Biomarkers in Gilbert’s Syndrome: A Secondary Analysis of Two Case-Control Studies

Stronger protective effects for GS subjects were demonstrated in the older subgroup compared to those of the younger group, contributing to the explanation of why GS serves as an important protector in the pathogenesis of metabolic, oxidative stress related diseases.

Potential Cardiovascular Risk Protection of Bilirubin in End-Stage Renal Disease Patients under Hemodialysis

The data suggest that higher bilirubin levels are associated with beneficial effects in HD patients, by improving lipid profile and reducing the inflammatory grade, which might contribute to increase in iron availability.

High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: effect-modification by metabolic syndrome

hs-CRP is inversely related to bilirubin, suggesting that low bilirUBin is implicated in enhanced low-grade systemic inflammation, and the inverse relationship of SAA with bilirubsin was found to be absent in MetS, which could be attributable to MetS-associated abnormalities in HDL characteristics.

Does serum bilirubin prevent cardiovascular disease

Serum bilirubin levels may not always be associated with future metabolic or atherosclerotic diseases, and randomized controlled trials have failed to confirm a role for antioxidant supplementation in CVD prevention, although oxidative stress is involved in the pathogenesis of CVD.

Paradoxical Association Between Apolipoprotein B and Prognosis in Coronary Artery Disease: A 36,468 Chinese Cohort Study

A paradoxical association between baseline ApoB concentration and long-term all-cause mortality is found among coronary artery disease patients admitted to Guangdong Provincial People's Hospital in China, where malnutrition and bilirubin mainly mediate theApoB paradox.

Bilirubin concentration and cardiovascular risk profile

The results of this retrospective epidemiological investigation show that plasma bilirubin concentration is not associated with variations of hsCRP and the lipid profile in a large population of outpatients with no biochemical markers of liver disease.

Relationship between bilirubin concentration, coronary endothelial function, and inflammatory stress in overweight patients.

Results suggest that a high bilirubin level was associated with favorable coronary endothelial function in overweight patients, and the anti-inflammatory effects of bilirUBin may mediate this effect.

Serum bilirubin links UGT1A1*28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients.

A graded, reverse association was noted between serum bilirubin and adverse outcomes among chronic hemodialysis patients and the UGT1A1*28 polymorphism had strong effects on bilirUBin levels and the 7/7 genotype might have an important effect on reducing CVEs and death.

Decreased small dense LDL levels in Gilbert's syndrome.

Acute-Phase Serum Amyloid A: An Inflammatory Adipokine and Potential Link between Obesity and Its Metabolic Complications

The increased expression of A-SAA by adipocytes in obesity suggests that it may play a critical role in local and systemic inflammation and free fatty acid production and could be a direct link between obesity and its comorbidities, such as insulin resistance and atherosclerosis.

Relationships between serum total bilirubin levels and metabolic syndrome in Korean adults.